Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Nyxoah SA - Ordinary Shares (NQ:NYXH)

5.270 +0.150 (+2.93%)
Streaming Delayed Price Updated: 9:57 AM EST, Jan 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Nyxoah SA - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2025 and Provides Revenue Guidance for the First Quarter of 2026
From Nyxoah
Via GlobeNewswire
News headline image
Publication relating to transparency notification
From Nyxoah
Via GlobeNewswire
News headline image
Nyxoah to Present at the 44th Annual J.P. Morgan Healthcare Conference
From Nyxoah
Via GlobeNewswire
News headline image
Nyxoah Announces Issuance of First Tranche of Convertible Bonds
From Nyxoah
Via GlobeNewswire
News headline image
Earnings Scheduled For November 13, 2025 ↗
 
Via Benzinga
News headline image
Nyxoah SA (NASDAQ: NYXH): A Deep Dive into its Bilateral Approach to Sleep Apnea
Nyxoah SA (NASDAQ: NYXH; Euronext Brussels: NYXH) is a Belgium-based medical technology company making significant strides in the treatment of Obstructive Sleep Apnea (OSA). The company is currently in... 
Via PredictStreet
Topics Initial Public Offering Intellectual Property
News headline image
Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Netherlands
From Nyxoah
Via GlobeNewswire
News headline image
Publication relating to transparency notifications
From Nyxoah
Via GlobeNewswire
News headline image
Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference
From Nyxoah
Via GlobeNewswire
News headline image
Nyxoah SA Stock Rises Pre-Market After CMS Raises Reimbursement For Sleep Disorder Therapy ↗
Nyxoah expects the stronger reimbursement framework to support broader adoption, increase procedural throughput, and expand across Medicare-heavy institutions. 
Via Stocktwits
News headline image
Nyxoah’s Genio® Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule
From Nyxoah
Via GlobeNewswire
News headline image
Information on the total number of voting rights and shares
From Nyxoah
Via GlobeNewswire
News headline image
Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio
From Nyxoah
Via GlobeNewswire
News headline image
Nyxoah (NYXH) Q3 2025 Earnings Call Transcript ↗
Nyxoah (NYXH) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Bonds Earnings Economy
News headline image
Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio
From Nyxoah
Via GlobeNewswire
News headline image
Nyxoah Reports Third Quarter 2025 Financial and Operating Results
From Nyxoah
Via GlobeNewswire
News headline image
Nyxoah to Participate in the Stifel 2025 Healthcare Conference
From Nyxoah
Via GlobeNewswire
News headline image
Nyxoah to Release Third Quarter 2025 Financial Results on November 13, 2025
From Nyxoah
Via GlobeNewswire
News headline image
Inspire Medical Systems Soars 3.9% on Groundbreaking Inspire V Clinical Data
Minneapolis, MN – October 13, 2025 – Inspire Medical Systems (NYSE: INSP) emerged as a standout performer in today's trading session, witnessing its stock price jump by an impressive 3.9% by the... 
Via MarketMinute
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
US-Listed Nyxoah Shares Soar On First Genio System Implants In Patients With Sleep Disorder ↗
Nyxoah CEO Olivier Taelman said that the company has also trained surgeons, obtained Value Analysis Committee approvals, and achieved successful coverage from major payors. 
Via Stocktwits
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Nyxoah Announces First U.S. Commercial Patients Implanted with Genio® System
From Nyxoah
Via GlobeNewswire
News headline image
Publication relating to transparency notifications
From Nyxoah
Via GlobeNewswire
News headline image
Nyxoah Provides an Update on Expanded Middle East Presence
From Nyxoah
Via GlobeNewswire
News headline image
Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.
From Nyxoah
Via GlobeNewswire
News headline image
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet ↗
 
Via Benzinga
News headline image
Publication relating to transparency notifications
From Nyxoah
Via GlobeNewswire
News headline image
Nyxoah Announces Upcoming Investor Events
From Nyxoah
Via GlobeNewswire
News headline image
Information on the total number of voting rights and shares
From Nyxoah
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.